187 related articles for article (PubMed ID: 35933701)
1. Roles of apelin/APJ system in cancer: Biomarker, predictor, and emerging therapeutic target.
Chen J; Li Z; Zhao Q; Chen L
J Cell Physiol; 2022 Oct; 237(10):3734-3751. PubMed ID: 35933701
[TBL] [Abstract][Full Text] [Related]
2. Apelin/APJ system and cancer.
Yang Y; Lv SY; Ye W; Zhang L
Clin Chim Acta; 2016 Jun; 457():112-6. PubMed ID: 27083318
[TBL] [Abstract][Full Text] [Related]
3. Multiple roles of apelin/APJ system in eye diseases.
Luo J; Zhao Q; Li Z; Chen L
Peptides; 2022 Jun; 152():170767. PubMed ID: 35181348
[TBL] [Abstract][Full Text] [Related]
4. Apelin/APJ system: A novel promising therapy target for pathological angiogenesis.
Wu L; Chen L; Li L
Clin Chim Acta; 2017 Mar; 466():78-84. PubMed ID: 28025030
[TBL] [Abstract][Full Text] [Related]
5. Role of Apelin/APJ axis in cancer development and progression.
Masoumi J; Jafarzadeh A; Khorramdelazad H; Abbasloui M; Abdolalizadeh J; Jamali N
Adv Med Sci; 2020 Mar; 65(1):202-213. PubMed ID: 32087570
[TBL] [Abstract][Full Text] [Related]
6. Function and regulation of apelin/APJ system in digestive physiology and pathology.
Huang Z; Luo X; Liu M; Chen L
J Cell Physiol; 2019 Jun; 234(6):7796-7810. PubMed ID: 30390294
[TBL] [Abstract][Full Text] [Related]
7. Adipokine Apelin/APJ Pathway Promotes Peritoneal Dissemination of Ovarian Cancer Cells by Regulating Lipid Metabolism.
Dogra S; Neelakantan D; Patel MM; Griesel B; Olson A; Woo S
Mol Cancer Res; 2021 Sep; 19(9):1534-1545. PubMed ID: 34172534
[TBL] [Abstract][Full Text] [Related]
8. Apelin/APJ system: an emerging therapeutic target for neurological diseases.
Li A; Zhao Q; Chen L; Li Z
Mol Biol Rep; 2023 Feb; 50(2):1639-1653. PubMed ID: 36378421
[TBL] [Abstract][Full Text] [Related]
9. Apelin/APJ system: an emerging therapeutic target for respiratory diseases.
Yan J; Wang A; Cao J; Chen L
Cell Mol Life Sci; 2020 Aug; 77(15):2919-2930. PubMed ID: 32128601
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Apelin/APJ system expression in hepatocellular carcinoma as a function of clinical severity.
Cabiati M; Gaggini M; De Simone P; Del Ry S
Clin Exp Med; 2021 May; 21(2):269-275. PubMed ID: 33201338
[TBL] [Abstract][Full Text] [Related]
11. APJ Is Associated with Treatment Response in Gastric Cancer Patients Receiving Concurrent Chemoradiotherapy and Endostar Therapy.
Hao YZ; Li ML; Ning FL; Wang XW
Cancer Biother Radiopharm; 2017 May; 32(4):133-138. PubMed ID: 28514205
[TBL] [Abstract][Full Text] [Related]
12. The regulatory effects of the apelin/APJ system on depression: A prospective therapeutic target.
Tian Y; Wang R; Liu L; Zhang W; Liu H; Jiang L; Jiang Y
Neuropeptides; 2023 Dec; 102():102382. PubMed ID: 37716179
[TBL] [Abstract][Full Text] [Related]
13. Targeting drugs to APJ receptor: From signaling to pathophysiological effects.
Huang Z; He L; Chen Z; Chen L
J Cell Physiol; 2018 Jan; 234(1):61-74. PubMed ID: 30070701
[TBL] [Abstract][Full Text] [Related]
14. Apelin/APJ system in inflammation.
Wang X; Zhang L; Li P; Zheng Y; Yang Y; Ji S
Int Immunopharmacol; 2022 Aug; 109():108822. PubMed ID: 35605524
[TBL] [Abstract][Full Text] [Related]
15. Apelin/APJ system as a therapeutic target in diabetes and its complications.
Hu H; He L; Li L; Chen L
Mol Genet Metab; 2016 Sep; 119(1-2):20-7. PubMed ID: 27650065
[TBL] [Abstract][Full Text] [Related]
16. Apelin/APJ signaling in hypoxia-related diseases.
He L; Xu J; Chen L; Li L
Clin Chim Acta; 2015 Dec; 451(Pt B):191-8. PubMed ID: 26436483
[TBL] [Abstract][Full Text] [Related]
17. The apelin-APJ system induces tumor arteriogenesis in hepatocellular carcinoma.
Muto J; Shirabe K; Yoshizumi T; Ikegami T; Aishima S; Ishigami K; Yonemitsu Y; Ikeda T; Soejima Y; Maehara Y
Anticancer Res; 2014 Oct; 34(10):5313-20. PubMed ID: 25275024
[TBL] [Abstract][Full Text] [Related]
18. APJ/apelin: A promising target for the treatment of retinopathy of prematurity.
Su J; Zhang Y; Kumar SA; Sun M; Yao Y; Duan Y
Drug Discov Today; 2022 Aug; 27(8):2342-2352. PubMed ID: 35561966
[TBL] [Abstract][Full Text] [Related]
19. Apelin inhibition prevents resistance and metastasis associated with anti-angiogenic therapy.
Uribesalgo I; Hoffmann D; Zhang Y; Kavirayani A; Lazovic J; Berta J; Novatchkova M; Pai TP; Wimmer RA; László V; Schramek D; Karim R; Tortola L; Deswal S; Haas L; Zuber J; Szűcs M; Kuba K; Dome B; Cao Y; Haubner BJ; Penninger JM
EMBO Mol Med; 2019 Aug; 11(8):e9266. PubMed ID: 31267692
[TBL] [Abstract][Full Text] [Related]
20. Cancer apelin receptor suppresses vascular mimicry in malignant melanoma.
Inukai K; Kise K; Hayashi Y; Jia W; Muramatsu F; Okamoto N; Konishi H; Akuta K; Kidoya H; Takakura N
Pathol Oncol Res; 2023; 29():1610867. PubMed ID: 36776217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
